164 related articles for article (PubMed ID: 27389143)
1. Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis.
DeCoteau W; Heckman KL; Estevez AY; Reed KJ; Costanzo W; Sandford D; Studlack P; Clauss J; Nichols E; Lipps J; Parker M; Hays-Erlichman B; Leiter JC; Erlichman JS
Nanomedicine; 2016 Nov; 12(8):2311-2320. PubMed ID: 27389143
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA.
Estevez AY; Ganesana M; Trentini JF; Olson JE; Li G; Boateng YO; Lipps JM; Yablonski SER; Donnelly WT; Leiter JC; Erlichman JS
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31623336
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
4. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain.
Heckman KL; DeCoteau W; Estevez A; Reed KJ; Costanzo W; Sanford D; Leiter JC; Clauss J; Knapp K; Gomez C; Mullen P; Rathbun E; Prime K; Marini J; Patchefsky J; Patchefsky AS; Hailstone RK; Erlichman JS
ACS Nano; 2013 Dec; 7(12):10582-96. PubMed ID: 24266731
[TBL] [Abstract][Full Text] [Related]
5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
Audet JN; Soucy G; Julien JP
Neuroscience; 2012 May; 209():136-43. PubMed ID: 22230045
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
[TBL] [Abstract][Full Text] [Related]
8. Redox-dependent catalase mimetic cerium oxide-based nanozyme protect human hepatic cells from 3-AT induced acatalasemia.
Singh R; Singh S
Colloids Surf B Biointerfaces; 2019 Mar; 175():625-635. PubMed ID: 30583218
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration.
Dardiotis E; Panayiotou E; Feldman ML; Hadjisavvas A; Malas S; Vonta I; Hadjigeorgiou G; Kyriakou K; Kyriakides T
Neurosci Lett; 2013 Aug; 548():170-5. PubMed ID: 23748038
[TBL] [Abstract][Full Text] [Related]
11. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
12. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
13. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
14. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
Seredenina T; Nayernia Z; Sorce S; Maghzal GJ; Filippova A; Ling SC; Basset O; Plastre O; Daali Y; Rushing EJ; Giordana MT; Cleveland DW; Aguzzi A; Stocker R; Krause KH; Jaquet V
Free Radic Biol Med; 2016 Aug; 97():95-108. PubMed ID: 27212019
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro.
Rando A; Gasco S; de la Torre M; García-Redondo A; Zaragoza P; Toivonen JM; Osta R
Neurodegener Dis; 2017; 17(1):1-13. PubMed ID: 27544379
[TBL] [Abstract][Full Text] [Related]
19. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphate on stability and catalase mimetic activity of cerium oxide nanoparticles.
Singh R; Singh S
Colloids Surf B Biointerfaces; 2015 Aug; 132():78-84. PubMed ID: 26011425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
